Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500, Nasdaq futures rise on tech boost
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
Insulet Reports Second Quarter 2016 Financial Results
August 3, 2016 4:01 PM EDTSecond Quarter Revenue of $87.3 Million, up 44% Year-Over-Year, Exceeds Expectations
Company Raises Mid-Point of Full Year 2016 Revenue Guidance by $10 Million
Gross Margin Improves to 57.8%
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months ended June... More
